Tumor predisposition syndrome | Detection of deletions and/or duplications in BAP1 gene by MLPA | 28 days | LV3080 | +Info |
Familial Aggregation Study | Detection of deletions and/or duplicationsin TP53 gene by MLPA | 28 days | LV2974 | +Info |
Gastric Cáncer | Detection of deletions and/or duplicationsin TP53 gene by MLPA | 28 days | LV2974 | +Info |
Hereditary Breast and Ovarian Cáncer | Detection of deletions and/or duplicationsin TP53 gene by MLPA | 28 days | LV2974 | +Info |
Li Fraumeni Syndrome | Detection of deletions and/or duplicationsin TP53 gene by MLPA | 28 days | LV2974 | +Info |
Pancreatic Cancer (Sd Peutz Jeghers, Pancreatitis) | Detection of deletions and/or duplicationsin TP53 gene by MLPA | 28 days | LV2974 | +Info |
Hereditary Breast and Ovarian Cáncer | Detection of large deletions and/or duplications in BRCA1 and BRCA2 genes by MLPA | 28 days | LV0187 | +Info |
Hereditary Breast and Ovarian Cáncer | Detection of large deletions and/or duplications in BRCA1 gene by MLPA | 28 days | LV1212 | +Info |
Hereditary Breast and Ovarian Cáncer | Detection of large deletions and/or duplications in BRCA2 gene by MLPA | 28 days | LV1213 | +Info |
Telangiectasia ataxia | Detection of large deletions and/or duplications in the ATM gene by MLPA | 28 days | LV1463 | +Info |
Peutz-Jeghers syndrome | Detection of large deletions and/or duplications in the STK11 gene by MLPA | 28 days | LV1574 | +Info |
Tuberous Sclerosis | Detection of large deletions and/or duplications in the TSC1 gene by MLPA | 28 days | LV0933 | +Info |
Tuberous Sclerosis | Detection of large deletions and/or duplications in the TSC2 gene by MLPA | 28 days | LV0934 | +Info |
Cowden syndrome | Detection of large deletions and/or duplicationsin PTEN gene by MLPA | 28 days | LV1351 | +Info |
Fanconi Anemia | Detection of large deletions and/orduplications in the FANCA gene by MLPA | 35 days | LV1586 | +Info |
Hereditary Breast and Ovarian Cáncer | Detection of the c.156_157insAlu mutation in the BRCA2 gene | 28 days | LV4126 | +Info |
Telangiectasia ataxia | geneNGS and Sanger sequencing of theATM | 42 days | LV1015 | +Info |
Hereditary Breast and Ovarian Cáncer | MAMMA GeneProfile: NGS and screening of deletions / duplications in the BRCA1 and BRCA2 genes. Sanger sequencing confirmation of pathological variants and MLPA confirmation of genomic rearrangements previously detected. | 28 days | LV1353 | +Info |
Juvenile Polyposis Syndrome | MLPA detection of large deletions and duplications in the SMAD4 and BMPR1A genes | 28 days | LV1354 | +Info |
Adenomatous polyposis, familial | NGS and bioinformatic CNVs screening, 12-gene panel:
APC, AXIN2, BRCA1, BRCA2, MLH1, MSH2, MSH6, MUTYH, NTHL1, POLD1, POLE, SCG5 | 42 days | LV4358 | +Info |
Pancreatic Cancer (Sd Peutz Jeghers, Pancreatitis) | NGS and bioinformatic CNVs screening, 13-gene panel: APC, ATM, BRCA1, BRCA2, CDKN2A, MLH1, MSH2, MSH6, PALB2, PMS2, STK11, TP53 |Sanger sequencing of the PRSS1 gene | 42 days | LV4354 | +Info |
Pheochromocytoma / Paraganglioma | NGS and bioinformatic CNVs screening, 13-gene panel: EPAS1, FH, KIF1B, MAX, MDH2, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, VHL | 42 days | LV4356 | +Info |
Gastric Cáncer, diffuse | NGS and bioinformatic CNVs screening, 14-gene panel:
APC, BRCA1, BRCA2, CDH1, CHEK2, CTNNA1, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS1, PMS2, TP53 | 42 days | LV4361 | +Info |
Prostate Cáncer, hereditary | NGS and bioinformatic CNVs screening, 14-gene panel: ATM, BRCA1, BRCA2, CHEK2, HOXB13, MLH1, MSH2, MSH6, MSR1, NBN, PALB2, PMS2, RAD51D, TP53 | 42 days | LV4278 | +Info |
Fanconi anemia | NGS and bioinformatic CNVs screening, 20-gene panel: BRCA1, BRCA2, BRIP1, ERCC4, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, PALB2, RAD51, RAD51C, SLX4, UBE2T, XRCC2 | 42 days | LV4331 | +Info |
Hereditary Breast and Ovarian Cáncer | NGS and bioinformatic CNVs screening, 22-gene panel:
ATM, BARD1, BLM, BRIP1, CDH1, CHEK2, ERCC4, MLH1, MSH2, MSH6, NBN, NF1, PALB2, PTEN, RAD51, RAD51C, RAD51D, RECQL, STK11, TP53, XRCC2, XRCC3 | 42 days | LV4353 | +Info |
Hereditary Breast and Ovarian Cáncer | NGS and bioinformatic CNVs screening, 24-gene panel: ATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, ERCC4, MLH1, MSH2, MSH6, NBN, NF1, PALB2, PTEN, RAD51, RAD51C, RAD51D, RECQL, STK11, TP53, XRCC2, XRCC3 | 42 days | LV4339 | +Info |
Gastrointestinal stromal tumor, familial (GIST) | NGS and bioinformatic CNVs screening, 7-gene panel: KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD | 42 days | LV4362 | +Info |
Nervous System/Brain Tumors | NGS and bioinformatic CNVs screening, 7-gene panel: NF1, NF2, POT1, RB1, TSC1, TSC2, VHL | 42 days | LV4359 | +Info |
Melanoma and Tumor predisposition syndrome | NGS and bioinformatic CNVs screening, 8-gene panel: BAP1, CDK4, CDKN2A, MC1R, MITF, POT1, TERT, XRCC3 | 42 days | LV4357 | +Info |
Renal Cancer (clear cell renal cancer, papillary renal cancer, Birt-Hogg-Dube syndrome) | NGS and bioinformatic CNVs screening, 8-gene panel: DIS3L2, FH, FLCN, HNF1A, HNF1B, MET, SDHB, VHL | 42 days | LV4355 | +Info |
Colorectal Cáncer, Hereditary Nonpolyposis | NGS and bioinformatic CNVs screening, 9-gene panel: BUB1, EPCAM, MLH1, MSH2, MSH6, PMS1, PMS2, POLD1, POLE | 42 days | LV4282 | +Info |
Tuberous Sclerosis | NGS of 2 gene panel:TSC1, TSC2 | 42 days | LV3172 | +Info |
Juvenile polyposis syndrome | NGS of 4 gene panel: BMPR1A, GREM1, PTEN, SMAD4and MLPA confirmation of CNVs previously detectedin BMPR1A, PTEN, SMAD4 genes | 42 days | LV3630 | +Info |
Xeroderma Pigmentosum, COFS, Cockayne and De Sanctis-Cacchione syndromes | NGS of 10 gene panel: DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, ERCC6, POLH, XPA, XPC | 42 days | LV3637 | +Info |
Hereditary Cáncer Syndromes | NGS of 111 gene panel:APC, ATM, ATR, AXIN2, BAP1, BARD1, BLM, BMPR1A,BRCA1, BRCA2, BRIP1, BUB1, CDH1, CDK4, CDKN1B,CDKN2A, CHEK2, DDB2, DICER1, DIS3L2, DKC1, ELANE, EPAS1, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5,ERCC6, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF,FANCG, FANCI, FANCL, FANCM, FH, FLCN, G6PC3, GFI1,GREM1, HOXB13, JAGN1, KIF1B, KIT, MAX, MDH2, MEN1, MET, MITF, MLH1, MNX1, MSH2, MSH6, MSR1, MUTYH, NBN, NF2, NFIX, NHP2, NOP10, NSD1, NTHL1, PALB2,PARN, PDGFRA, PMS1, POLD1, POLE, POLH, POT1,PRKAR1A, PTCH1, PTEN, RAD50, RAD51, RAD51C, RAD51D, RB1, RECQL, RECQL4, RET, RTEL1, SCG5,SLX4, SMAD4, SMARCA4, STK11, SUFU, TERC, TERT,TINF2, TMEM127, TP53, TSC1, TSC2, UBE2T, VHL,VPS45, WAS, WRN, WT1, XPA, XPC, XRCC2 | 56 days | LV3651 | +Info |
Syndromes in Pediatric Oncology: Wilms, Bloom, Sotos, Nijmgen, Perlman, Currarino, Rothmund-Thomson, Werner. | NGS of 11 gene panel: BLM, NBN, NSD1, RAD50, WT1, DIS3L2, MNX1, NFIX, RECQL4, WRN, SMARCA4 | 42 days | LV3644 | +Info |
Ataxia Telangiectasia | NGS of 2 gene panel: ATM, ATR. | 42 days | LV3627 | +Info |
Sarcoma, familial | NGS of 2 gene panel: DICER1, POT1. | 42 days | LV3649 | +Info |
Basal cell nevus syndrome, Gorlin syndrome | NGS of 2 gene panel: PTCH1, SUFU | 42 days | LV3645 | +Info |
Familial Aggregation Study | NGS of 40 gene panel: APC, ATM, AXIN2, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1, CDH1, CDKN2A, CHEK2, DICER1, EPCAM, GREM1, KIT, MEN1, MLH1, MSH2, MSH6, MUTYH, NBN, NTHL1, PALB2, PDGFRA, PMS1, POLD1, POLE, PTEN, RAD50, RAD51C, RAD51D, SCG5, SMAD4, SMARCA4, STK11, TP53, TSC1, TSC2, VHL . | 42 days | LV3650 | +Info |
Li Fraumeni, Li Fraumeni like, syndromes | NGS of 4 gene panel: CHEK2, TP53, POT1, DICER1, | 42 days | LV3642 | +Info |
Hamartoma tumor Polyposis syndromes | NGS of 5 gene panel: BMPR1A, SMAD4, PTEN, STK11, DIS3L2. | 42 days | LV3643 | +Info |
Neutropenia, severe congenital | NGS of 6 gene panel: ELANE, G6PC3, GFI1, JAGN1, VPS45, WAS and Sanger sequencing of the HAX1 gene | 42 days | LV3638 | +Info |
Endocrine tumors ( Pituitary adenoma, MEN2/ CMT, MEN1, Von Hippel Lindau, Carney complex) | NGS of 7 gene panel: AIP, CDKN1B, RET, MEN1, VHL, PRKAR1A, DICER1 | 42 days | LV3634 | +Info |
Dyskeratosis congenita | NGS of 9 gene panel: ACD, DKC1, NHP2, NOP10, PARN, RTEL1, TERC, TERT, TINF2 | 42 days | LV3631 | +Info |
Retinoblastoma | NGS of the RB1 gene | 28 days | LV3648 | +Info |
Adenomatous polyposis, familial | Sanger Sequencing of the APC gene | 42 days | LV0233 | +Info |
Tumor predisposition syndrome | Sanger Sequencing of the BAP1 gene | Consult | LV2964 | +Info |
Juvenile Polyposis Syndrome | Sanger sequencing of the BMPR1A gene | Consult | LV1326 | +Info |
Gastric Cáncer, diffuse | Sanger Sequencing of the CDH1 gene | 56 days | LV0311 | +Info |
Fanconi Anemia | Sanger Sequencing of the FANCA gene | 42 days | LV1847 | +Info |
Birt-Hogg-Dube syndrome | Sanger Sequencing of the FLCN gene | 56 days | LV2566 | +Info |
Prostate Cancer, familial | Sanger sequencing of the HOXB13 gene | 42 days | LV4222 | +Info |
Muir-Torre syndrome | Sanger Sequencing of the MLH1 gene | 42 days | LV0182 | +Info |
Colorectal adenomatous polyposis, autosomal recessive, with pilomatric | Sanger sequencing of the MUTYH gene | 42 days | LV0787 | +Info |
Cowden syndrome | Sanger sequencing of the PIK3CA gene | 49 days | LV3284 | +Info |
Colorectal cancer, hereditary nonpolyposis, type 4 | Sanger Sequencing of the PMS2 gene | 56 days | LV2567 | +Info |
Cowden syndrome | Sanger sequencing of the PTEN gene | 42 days | LV0804 | +Info |
Hereditary Breast and Ovarian Cáncer | Sanger Sequencing of the RAD51C gene | Consult | LV1184 | +Info |
Juvenile Polyposis Syndrome | Sanger Sequencing of the SMAD4 gene | Consult | LV2629 | +Info |
Peutz-Jeghers syndrome | Sanger Sequencing of the STK11 gene | 35 days | LV0150 | +Info |
Li Fraumeni Syndrome | Sanger sequencing of the TP53 gene | 35 days | LV0706 | +Info |
Xeroderma Pigmentosum | Sanger Sequencing of the XPA gene | Consult | LV0989 | +Info |
Xeroderma Pigmentosum | Sanger Sequencing of the XPC gene | 56 days | LV0988 | +Info |
Pheochromocytoma / Paraganglioma | Sanger sequencing of the SDHA, SDHB, SDHC, SDHD genes. | 63 days | LV3833 | +Info |
Renal Cancer (clear cell renal cancer, papillary renal cancer, Birt-Hogg-Dube syndrome) | Sanger sequencing of the SDHA, SDHB, SDHC, SDHD genes. | 63 days | LV3833 | +Info |